These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 28577282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.
    Oncogene; 2008 Feb 07; 27(7):1019-32. PubMed ID: 17700529
    [Abstract] [Full Text] [Related]

  • 4. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.
    J Biol Chem; 2005 Dec 30; 280(52):43188-97. PubMed ID: 16219765
    [Abstract] [Full Text] [Related]

  • 5. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 30; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
    Jin W, Chen Y, Di GH, Miron P, Hou YF, Gao H, Shao ZM.
    J Biol Chem; 2008 Oct 31; 283(44):29671-80. PubMed ID: 18765668
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK, Brown M.
    Mol Endocrinol; 2005 Jun 31; 19(6):1543-54. PubMed ID: 15802375
    [Abstract] [Full Text] [Related]

  • 8. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.
    Biochim Biophys Acta; 2008 Jun 31; 1783(6):1220-8. PubMed ID: 18302941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.
    Jonsson P, Katchy A, Williams C.
    Endocr Relat Cancer; 2014 Apr 31; 21(2):143-60. PubMed ID: 24192230
    [Abstract] [Full Text] [Related]

  • 12. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC, Frasor J, Komm B, Katzenellenbogen BS.
    Endocrinology; 2006 Oct 31; 147(10):4831-42. PubMed ID: 16809442
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, Das GM.
    Proc Natl Acad Sci U S A; 2010 Aug 24; 107(34):15081-6. PubMed ID: 20696891
    [Abstract] [Full Text] [Related]

  • 14. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
    Koyama S, Wada-Hiraike O, Nakagawa S, Tanikawa M, Hiraike H, Miyamoto Y, Sone K, Oda K, Fukuhara H, Nakagawa K, Kato S, Yano T, Taketani Y.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):357-62. PubMed ID: 20074560
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL.
    Mol Cell Biol; 2007 Sep 01; 27(17):5933-48. PubMed ID: 17591692
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
    Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, Nassa G, Tarallo R, Cantarella C, Rizzo F, Di Benedetto A, Mottolese M, Benes V, Ambrosino C, Nola E, Weisz A.
    Oncogene; 2012 Sep 20; 31(38):4196-206. PubMed ID: 22231442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.